Significant Ownership of Murchinson Ltd.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Murchinson Ltd. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Marc J. Bistricer - Marc J. Bistricer, Chief Executive Officer
- Manager location
- Toronto
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Murchinson Ltd. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Murchinson Ltd.
Significant Ownership of Murchinson Ltd.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VBIO | Valion Bio, Inc. | Common Stock, par value $0.0001 per share | 10% | $242,133 | 440,242 | Murchinson Ltd. | 08 Jun 2026 | ||
| PTHS | Pelthos Therapeutics Inc. | Common Stock, par value $0.0001 per share | 9.1% | $7,840,000 | 280,000 | Murchinson Ltd. | 30 Sep 2025 | ||
| NNDM | Nano Dimension Ltd. | Ordinary Shares par value NIS 5.00 per share | 8.1% | $24,847,600 | -$4,566,302 | 17,136,276 | -16% | Murchinson Ltd. | 17 Jul 2026 |
Schedules 13D/G Reported by Murchinson Ltd.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.